|
Ms. Jackson has been fully immersed in the pharmaceutical industry since 1989. Her experience encompasses every aspect of the clinical research process from protocol writing to project management and operational administration of multi-state research trials. To date, Ms. Jackson has actively executed and or managed over 500 Phase I-III research protocols.Trained as an RN, Ms. Jackson worked in a medical setting for over 13 years. She has a comprehensive understanding of the science behind pharmaceutical formulations, as well as first-hand knowledge regarding the needs of medical providers and patients.Ms. Jackson has combined her leadership and clinical talents to excel in the professional realm of clinical trial research focused primarily in analgesia. She advanced from Study Coordination and Project Management at a small site in Salt Lake City to become Senior Director of Clinical Site Operations for a large out-of state CRO. While Senior Director, Ms. Jackson contributed significantly to the developed of the acute post-operative bunionectomy model. Her contributions to the post-operative bunionectomy model are now recognized worldwide as the standard for acute pain drug development.In 2003, Ms. Jackson joined forces with Lynn R. Webster, MD to found Lifetree Clinical Research®. As President and Chief Executive Officer, Ms. Jackson has led Lifetree to experience exponential growth. In 2006 alone, the company grew from 13 to 46 employees, and revenues increased 98 percent. Lifetree is currently the most highly-respected and fastest-growing clinical research organization in the Mountain West Region.Ms Jackson was President of the Salt Lake City Chapter of ACRP in 2004. The chapter was in its infancy and she facilitated top regulatory and FDA speakers to educate other research professional within the community. Recently, Ms Jackson was asked to serve on the Utah Technology Council’s Life Science Advisory Council. Ms. Jackson’s uncompromising drive for excellence and quality research will undoubtedly promise to build Lifetree’s propensity in forging new frontiers within the biopharmaceutical industry. | 